Leishmaniases of the New World: Current concepts and implications for future research

Clinical Microbiology Reviews

Volumn 6, Issue 3, 1993, Pages 230-250

  Grimaldi Jr , Gabriel ^a   Tesh, Robert B ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMASTIGOTE; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENETIC VARIABILITY; GENOME; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; INFLAMMATION; INGESTION; LABORATORY DIAGNOSIS; LEISHMANIASIS; MUTATION; NONHUMAN; PARASITE VECTOR; PARASITE VIRULENCE; PROMASTIGOTE; PUBLIC HEALTH; REVIEW; TAXONOMY; VIRULENCE; WESTERN HEMISPHERE; ZOONOSIS;

ANIMAL; HUMAN; LEISHMANIA; LEISHMANIASIS; PREVALENCE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027317582     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.6.3.230     Document Type: Article

References (328)

1. Aguilar, C. M., E. F. Rangel, L. Garcia, E. Fernandez, H. Momen, and G. Grimaldi, Jr. 1989. Zoonotic cutaneous leishmaniasis due to Leishmania (Vlannia) braziliensis associated with domestic animals in Venezuela and Brazil. Mem. Inst. Oswaldo Cruz 84:19-28.
2. Akuffo, H., M. Dietz, S. Teklemariam, T. Tadesse, G. Amare, and B. Yemane. 1990. The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica. Trans. R. Soc. Trop. Med. Hyg. 84:532-534.
3. Akuffo, H. O., T. E. Fehniger, and S. Britton. 1988. Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression. J. Immunol. 141:2461-2466.
4. Alencar, J. E., Y. M. Almeida, Z. F. Silva, A. S. Paiva, and M. F. Fonseca. 1974/1975. Aspectos atuais do calazar no Ceara. Rev. Bras. Malariol. Doencas Trop. 26:27-53.
5. Alters, J., A. Salas, M. Riera, M. Udina, A. Galmes, J. Balanzat, A. Ballesteros, J. Buades, F. Salva, and C. Villalonga. 1991. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS 5:201-207.
6. Alvar, J., J. Blazquez, and R. Najera. 1989. Association of visceral leishmaniasis and human immunodeficiency infections. J. Infect. Dis. 160:560-561.
7. Anez, N., E. Nieves, and D. Cazorla. 1989. The validity of the developmental pattern in the sandfly gut for classification of Leishmania. Trans. R. Soc. Trop. Med. Hyg. 83:634-635.
8. Anthony, R. L., M. Grogl, J. B. Sacci, and R. W. Ballou. 1987. Rapid detection of Leishmania amastigotes in fluid aspirates and biopsies of human tissues. Am. J. Trop. Med. Hyg. 37:271-276.
9. Antunes, C. M. F., W. Mayrink, P. A. Magalhaes, C. A. Costa, M. N. Melo, M. Dias, M. S. M. Michalick, P. Williams, A. Oliveira Lima, J. B. F. Vieira, and A. P. M. Schettini. 1986. Controlled field trials of a vaccine against New World cutaneous leishmaniasis. Int. J. Epidemiol. 15:572-579.
10. Arana, M. M., D. A. Evans, A. Zolessi, A. Llanos-Cuentas, and Arevalo. 1990. Biochemical characterization of Leishmania (Viannia) braziliensis and Leishmania (Viannia) peruviana by isoenzymes. Trans. R. Soc. Trop. Med. Hyg. 90:526-529.
11. Arias, J. R., M. A. Miles, R. D. Naiff, M. M. Povoa, R. A. de Freitas, C. B. Biancardi, and E. G. Castellon. 1985. Flagellate infections of Brazilian sandflies (Diptera:Psychodidae). Isolation in vitro and biochemical identification of Endotrypanum and Leishmania. Am. J. Trop. Med. Hyg. 34:1098-1108.
12. Aston, D. L., and A. P. Thorley. 1970. Leishmaniasis in Central Brazil: results of a Montenegro skin test survey among amerindians in Xingu National Park. Trans. R. Soc. Trop. Med. Hyg. 64:671-678.
13. Badaro, R., E. M. Carvalho, H. Rocha, A. C. Queiroz, and T. C. Jones. 1987. Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet 1:647-649.
14. Badaro, R., E. Falcoff, F. S. Badaro, E. M. Carvalho, D. Pedral-Sampaio, A. Barrai, J. S. Carvalho, M. Barral-Netto, Brandely, L. Silva, J. C. Bina, R. Teixeira, R. Falcoff, H. Rocha, J. L. Ho, and W. D. Johnson, Jr. 1990. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N. Engl. J. Med. 322:16-21.
15. Badaro, R., R. Falcoff, M. Brandely, M. Barral-Neto, E. Carvalho, and E. Falcoff. 1989. Treatment of visceral and diffuse leishmaniasis by interferon gamma. J. Interferon Res. (Suppl. 2):S134.
16. Badaro, R., T. C. Jones, E. M. Carvalho, D. Sampaio, S. G. Reed, A. Barrai, R. Teixeira, and W. D. Johnson, Jr. 1986. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 154:1003-1011.
17. Badaro, R., T. C. Jones, R. Lorenco, B. J. Cerf, D. Sampaio, E. M. Carvalho, H. Rocha, R. Teixeira, and W. D. Johnson, Jr. 1986. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J. Infect. Dis. 154:639-649.
18. Badaro, R., S. G. Reed, A. Barrai, G. Orge, and T. C. Jones. 1986. Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses. Am. J. Trop. Med. Hyg. 35:72-78.
19. Badaro, R., D. Pedral-Sampaio, W. D. Johnson, Jr., and S. G. Reed. 1990. Evaluation of stability of a soluble intradermal skin test antigen preparation in American visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 84:226-227.
20. Ballou, W. R., J. B. McClain, D. M. Gordon, G. D. Shanks, J. Andujar, J. D. Berman, and J. D. Chulay. 1987. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis. Lancet ii:13-16.
21. Balzan, M., and F. Fenech. 1992. Acute renal failure in visceral leishmaniasis treated with sodium stibogluconate. Trans. R. Soc. Trop. Med. Hyg. 86:515-516.
22. Barker, D. C. 1987. DNA diagnosis of human leishmaniasis. Parasitol. Today 3:177-184.
23. Barker, D. C. 1989. Molecular approaches to DNA diagnosis. Parasitology 99(Suppl.):S125-S146.
24. Barker, D. C., J. Butcher, L. J. Gibson, W. P. K. Kennedy, R. H. Williams, C. A. Cuba, P. D. Marsden, R. Lainson, and J. J. Shaw. 1986. Sequence homology of kinetoplast DNA in Leishmania studied by filter hybridization of endonuclease digested fragments and in situ hybridization of individual organisms, p. 41-55. In J.-A. Rioux (ed.), Leishmania, taxonomie et phylogenese. Applications ecoepidemiologiques. Institut Mediterraneen d'Etudes Epidemiologiques et Ecologiques, Montpellier, France.
25. Barral, A., E. M. Carvalho, R. Badaro, and M. Barral-Neto. 1986. Suppression of lymphocyte proliferative responses by sera from patients with American visceral leishmaniasis. Am. J. Trop. Med. Hyg. 35:735-742.
26. Barral, A., D. Pedral-Sampaio, G. Grimaldi, Jr., H. Momen, D. McMahon-Pratt, A. R. de Jesus, R. Almeida, R. Badaro, M. Barral-Neto, E. M. Carvalho, and W. D. Johnson. 1991. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am. J. Trop. Med. Hyg. 44:536-546.
27. Barral-Neto, M., A. Barral, C. E. Brownell, Y. A. W. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-B in leishmanial infection: a parasite escape mechanism. Science 257:545-548.
28. Barral-Neto, M., A. Barrai, S. B. Santos, E. M. Carvalho, R. Badaro, H. Rocha, S. G. Reed, and W. D. Johnson, Jr. 1991. Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J. Immunol. 147:281-284.
29. Bastien, P., C. Blaineau, M. Taminh, J.-A. Rioux, G. Roizes, and M. Pages. 1990. Interclonal variations in molecular karyotype in Leishmania infantum imply a "mosaic" strain structure. Mol. Biochem. Parasitol. 40:53-62.
30. Belosevic, M., C. E. Davis, M. S. Meltzer, and C. A. Nacy. 1988. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. J. Immunol. 141:890-896.
31. Belosevic, M., D. S. Finbloom, P. H. Van Der Meide, M. V. Slayter, and C. A. Nacy. 1989. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143:266-274.
32. Berenguer, J., S. Moreno, E. Cercenado, J. C. L. Bernaldo de Quiros, A. G. Fuente, and E. Bouza. 1989. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann. Intern. Med. 111:129-132.
33. Berman, J. D. 1988. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies. Rev. Infect. Dis. 10:560-586.
34. Berman, J. D., and D. H. Dwyer. 1981. Expression of Leishmania antigen on the surface of infected human macrophages in vitro. Clin. Exp. Immunol. 44:342-348.
35. Beverley, S. M. 1991. Gene amplification in Leishmania. Annu. Rev. Microbiol. 45:417-444.
36. Beverley, S. M., and C. M. Coburn. 1990. Recurrent de novo appearance of small linear DNAs in Leishmania major and relationship to extra-chromosomal DNAs in other species. Mol. Biochem. Parasitol. 42:133-142.
37. Beverley, S. M., R. B. Ismach, and D. McMahon-Pratt. 1987. Evolution of the genus Leishmania as revealed by comparisons of nuclear DNA restriction fragment patterns. Proc. Natl. Acad. Sci. USA 84:484-488.
38. Bishop, R. P., and F. Akinsehinwa. 1989. Characterization of Leishmania donovani stocks by genomic DNA heterogeneity and molecular karyotype. Trans. R. Soc. Trop. Med. Hyg83:629-634.
39. Blackwell, J. M. 1992. Leishmaniasis epidemiology: all down to the DNA. Parasitology 104(Suppl.):S19-S34.
40. Blackwell, J. M., and J. Alexander. 1986. Different host genes recognize and control infection with taxonomically distinct Leishmania species, p. 211-219. In J.-A. Rioux (ed.), Leishmania: taxonomie et phylogenese. Aplications ecoepidemiologiques. Institut Mediterraneen d'Etudes Epidemiologiques et Ecologiques, Montpellier, France.
41. Bonfante-Garrido, R., E. Melendez, S. Barroeta, M. A. Mejia de Alejos, H. Momen, E. Cupolillo, and G. Grimaldi, Jr. 1992. Cutaneous leishmaniasis in western Venezuela caused by infection with Leishmania venezuelensis and L. braziliensis variants. Trans. R. Soc. Trop. Med. Hyg. 86:141-148.
42. Borelli, D. A. 1987. Clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev. Infect. Dis. 9(Suppl. I):S57-S63.
43. Bryceson, A. 1987. Therapy in man, p. 847-907. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniasis in biology and medicine, vol. 2. Academic Press, Ltd., London.
44. Bryceson, A. D. M., J. D. Chulay, M. Ho, M. Mugambii, J. B. Were, R. Muigai, C. Change, G. Gachihi, J. Meme, G. Anabwani, and S. M. Bhatt. 1985. Visceral leishmaniases unresponsive to antimonial drugs. I. Clinical and immunological studies. Trans. R. Soc. Trop. Med. Hyg. 79:700-704.
45. Bryceson, A. D. M., J. D. Chulay, M. Mugambi, J. B. Were, G. Gachihi, R. Muigai, S. M. Bhatt, M. Ho, C. N. Chunge, H. C. Spencer, J. Meme, and G. Anabwani. 1985. Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine. Trans. R. Soc. Trop. Med. Hyg. 79:705-714.
46. Burns, J. M., Jr., J. M. Scott, E. M. Carvalho, D. M. Russo, C. J. March, K. P. Van Ness, and S. G. Reed. 1991. Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses. J. Immunol. 146: 742-748.
47. Button, L. L., D. G. Russell, H. Klein, E. Medina-Acosta, R. E. Karess, and W. R. McMaster. 1989. Genes encoding the major surface glycoprotein in Leishmania are tandemly linked at a single chromosomal locus and are constitutively transcribed. Mol. Biochem. Parasitol. 32:271-284.
48. Carvalho, E. M., B. S. Andrews, R. Martinelli, M. Dutra, and H. Rocha. 1983. Circulating immune complexes and rheumatoid factor in schistosomiasis and visceral leishmaniasis. Am. J. Trop. Med. Hyg. 32:61-69.
49. Carvalho, E. M., O. Bacellar, A. Barral, R. Badaro, and W. D. Johnson, Jr. 1989. Antigen specific immunosuppression in visceral leishmaniasis is cell mediated. J. Clin. Invest. 83:860-864.
50. Carvalho, E. M., R. Badaro, S. G. Reed, T. Jones, and W. D. Johnson, Jr. 1985. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Invest. 76:2066-2069.
51. Carvalho, E. M., A. Barrai, D. Pedral-Sampaio, M. Barral-Netto, R. Badaro, H. Rocha, and W. D. Johnson, Jr. 1992. Immunological markers of clinical evolution in children recently infected with L. chagasi. J. Infect. Dis. 165:536-544.
52. Carvalho, E. M., W. R. Johnson, Jr., E. Barreto, P. D. Marsden, J. L. M. Costa, S. Reed, and H. Rocha. 1985. Cell mediated immunity in American cutaneous and mucocutaneous leishmaniasis. J. Immunol. 135:4144-4148.
53. Castes, M., A. Agnelli, and A. J. Rondon. 1984. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis. Clin. Exp. Immunol. 57:279-286.
54. Castes, M., A. Agnelli, O. Verde, and A. J. Rondon. 1984. Characterization of the cellular immune response in American cutaneous leishmaniasis. Clin. Immunol. Immunopathol. 27: 176-186.
55. Champsi, J. A., and D. McMahon-Pratt. 1988. Membrane glycoprotein M-2 protects against Leishmania amazonensis infection. Infect. Immun. 52:3272-3279.
56. Chan, M. M.-Y., and D. Fong. 1990. Inhibition of leishmanias but not host macrophages by the antitubulin herbicide trifluralin. Science 249:924-925.
57. Chang, K.-P., G. Chauduri, and D. Fong. 1990. Molecular determinants of Leishmania virulence. Annu. Rev. Microbiol. 44:499-529.
58. Chang, K.-P., D. Fong, and R. S. Bray. 1985. Biology of Leishmania and leishmaniasis, p. 1-30. In K.-P. Chang and R. S. Bray (ed.), Leishmaniasis. Elsevier, London.
59. Chaniotis, B. N., R. E. Parsons, H. J. Harlan, and M. A. Correa. 1982. A pilot study to control phlebotomine sand flies (Diptera: Psychodidae) in a neotropical rain forest. J. Med. Entomol. 19:1-5.
60. Choudhry, A., P. Y. Guru, R. P. Saxena, A. Tandon, and K. C. Saxena. 1990. Enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Bhadohi (Varanasi), India. Trans. R. Soc. Trop. Med. Hyg. 84:363-366.
61. Chunge, C. N., G. Gachihi, R. Muigai, K. Wasunna, J. R. Rashid, J. D. Chulay, G. Anabwani, C. N. Oster, and A. D. M. Bryceson. 1985. Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinal. Trans. R. Soc. Trop. Med. Hyg. 79:715-718.
62. Cillari, E., M. Dieli, E. Maltese, S. Milano, A. Salerno, and F. Y. Liew. 1989. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma. J. Immunol. 143:2001-2005.
63. Cillari, E., F. Y. Liew, and R. Lelchuk. 1986. Suppression of interleukin-2 production by macrophages in susceptible BALB/c mice infected with Leishmania major. Infect. Immun. 54:386-394.
64. Cillari, E., S. Milano, M. Dieli, E. Maltese, S. Di Rosa, S. Mansueto, A. Salerno, and F. Y. Liew. 1991. Reduction in the number of UCHL-1T cells and IL-2 production in the peripheral blood of patients with visceral leishmaniasis. J. Immunol. 146:1026-1030.
65. Convit, J., P. L. Castellanos, M. Ulrich, M. Castes, A. Rondon, M. E. Pinardi, N. Rodriguez, B. R. Bloom, S. Formica, L. Valecillos, and A. Bretana. 1989. Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. J. Infect. Dis. 160:104-115.
66. Convit, J., M. E. Pinardi, and A. J. Rondon. 1972. Diffuse cutaneous leishmaniasis: a disease due to immunological defect of the host. Trans. R. Soc. Trop. Med. Hyg. 66:603-610.
67. Copeland, H. W., B. A. Arana, and T. R. Navin. 1990. Comparison of active and passive case detection of cutaneous leishmaniasis in Guatemala. Am. J. Trop. Med. Hyg. 43:257-259.
68. Corredor, A., J. F. Gallego, R. B. Tesh, A. Morales, C. F. Carrasquilla, D. G. Young, R. D. Kreutzer, J. Boshell, M. T. Palau, E. Caceres, and D. Pelaez. 1989. Epidemiology of visceral leishmaniasis in Colombia. Am. J. Trop. Med. Hyg. 40:480-486.
69. Cruz, A., and S. M. Beverley. 1990. Gene replacement in parasitic protozoa. Nature (London) 348:171-174.
70. Da Cruz, A. M., E. S. Machado, J. A. Menezes, M. S. Rutowitsch, and S. G. Coutinho. Cellular and humoral immune responses in a case of American cutaneous leishmaniasis and HIV-associated infection. Trans. R. Soc. Trop. Med. Hyg., in press.
71. Darce, M., J. Moran, X. Palacios, A. Belli, F. Gomez-Urcuyo, D. Zamora, S. Valle, J. C. Gantier, H. Momen, and G. Grimaldi, Jr. 1991. Etiology of human cutaneous leishmaniasis in Nicaragua. Trans. R. Soc. Trop. Med. Hyg. 85:58-59.
72. Das Gupta, S., D. K. Ghosh, and H. K. Majumder. 1991. A cloned kinetoplast DNA mini-circle fragment from a Leishmania spp. specific for post-kala-azar dermal leishmaniasis strains. Parasitology 102:187-191.
73. Da Silva, R. P., B. F. Hall, K. A. Joiner, and D. L. Sacks. 1989. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J. Immunol. 143:617-622.
74. Datry, A., T. Similowski, P. Jais, M. Rosenheim, C. Katlama, E. Maheu, S. Kazaz, D. Fassin, M. Danis, and M. Gentilini. 1990. AIDS-associated leishmaniasis: an unusual gastroduodenal presentation. Trans. R. Soc. Trop. Med. Hyg. 84:239-240.
75. Davis, C. E., M. Belosevic, M. S. Meltzer, and C. A. Nacy. 1988. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection. J. Immunol. 141:627-635.
76. De Bruijn, M. H. L., and D. C. Barker. Diagnosis of New World leishmaniasis: relationships between and detection by amplification of kinetoplast DNA of species of the Leishmania braziliensis complex. Mol. Biochem. Parasitol., in press.
77. Dhaliwal, J. S., and F. Y. Liew. 1987. Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis. Infect. Immun. 55:645-651.
78. di Martino, L., M. P. Mantovani, L. Gradoni, M. Gramiccia, and S. Guandalini. 1990. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy. Trans. R. Soc. Trop. Med. Hyg. 84:534-535.
79. El-Safi, S. H., and D. A. Evans. 1989. A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan. Trans. R. Soc. Trop. Med. Hyg. 83:334-337.
80. Engelhorn, S., A. Bruckner, and H. G. Remold. 1990. A soluble factor produced by inoculation of human monocytes with Leishmania donovani promastigotes suppresses IFN-gamma-dependent monocyte activation. J. Immunol. 145:2662-2668.
81. Evans, D. A., W. P. R. Kennedy, S. Elbihari, C. Chapman, V. Smith, and W. Peters. 1989. Hybrid formation in the genus Leishmania? Parassitologia (Rome) 29:165-173.
82. Falqueto, A., P. A. Sessa, J. B. M. Vareja, G. C. Barros, H. Momen, and G. Grimaldi, Jr. Leishmaniasis due to Leishmania braziliensis (in Espirito Santo, Brazil). Further evidence on the role of dogs as reservoir of infection for humans. Mem. Inst. Oswaldo Cruz., in press.
83. + T cells in resistance to cutaneous leishmaniasis in immunized mice. J. Immunol. 142:2052-2056.
84. Franke, E. D., F. S. Wignall, M. E. Cruz, E. Rosalez, A. A. Tovar, C. M. Lucas, A. Llanos-Cuentas, and J. D. Berman. 1990. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann. Intern. Med. 113:934-940.
85. Gajewski, T. F., S. R. Schell, and F. W. Fitch. 1990. Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J. Immunol. 144:4110-4120.
86. Galvao-Castro, B., J. A. Sa Ferreira, K. F. Marzochi, M. C. A. Marzochi, S. G. Coutinho, and P. H. Lambert. 1984. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clin. Exp. Immunol. 56:58-66.
87. Garcia-Miss, M. R., F. J. Andrade-Narvaez, R. E. Esquivel-Vinas, E. B. Simmonds-Diaz, S. B. Canto-Lara, and A. L. Cruz-Ruiz. 1990. Localized cutaneous leishmaniasis (chiclero's ulcer) in Mexico: sensitivity and specificity of ELISA for IgG antibodies to Leishmania mexicana. Trans. R. Soc. Trop. Med. Hyg. 84:356-358.
88. Gardener, P. J. 1977. Taxonomy of the genus Leishmania. A review of nomenclature and classification. Trop. Dis. Bull. 74:1069-1088.
89. Ghalib, H. W., E. A. Eltoum, C. C. M. Kroon, and A. M. El Hassan. 1992. Identification of Leishmania from mucosal leishmaniasis by recombinant DNA probes. Trans. R. Soc. Trop. Med. Hyg. 86:158-160.
90. Giannini, S. H., S. S. Curry, R. B. Tesh, and L. H. T. Van der Ploeg. 1990. Sized-conserved chromosomes and stability of molecular karyotype in cloned stocks of Leishmania major. Mol. Biochem. Parasitol. 39:9-22.
91. Giannini, S. H., and N. G. Saravia. 1989. Application of molecular karyotype analysis to the epidemiology of recurrent cutaneous leishmaniasis from the Pacific Coast Region of Colombia. J. Cell Biochem. Suppl. 13E:90.
92. Glew, R. H., A. K. Saha, S. Das, and A. T. Remaley. 1988. Biochemistry of the Leishmania species. Microbiol. Rev. 52:412-432.
93. Gottlieb, M., and D. M. Dwyer. 1988. Plasma membrane functions: a biochemical approach to understanding the biology of Leishmania, p. 449-464. In P. T. Englund and A. Sher (ed.), The biology of parasitism. Alan R. Liss, New York.
94. Gramiccia, M., L. Gradoni, and M. Troiani. 1992. HIV-Leishmania co-infections in Italy. Isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients. Trans. R. Soc. Trop. Med. Hyg. 86:161-163.
95. Gramiccia, M., D. F. Smith, M. C. Angelici, P. D. Ready, and L. Gradoni. 1992. A kinetoplast DNA probe diagnostic for Leishmania infantum. Parasitology 105:29-34.
96. Green, S. J., R. M. Crawford, J. T. Hockmeyer, M. S. Meltzer, and C. A. Nacy. 1990. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J. Immunol. 145:4290-4297.
97. Greenblatt, C. L. 1985. Vaccination for leishmaniasis, p. 199-212. in K.-P. Chang and R. S. Bray (ed.), Leishmaniasis. Elsevier, London.
98. Greenblatt, C. L. 1988. Cutaneous leishmaniasis. The propects for a killed vaccine. Parasitol. Today 4:53-54.
99. Grimaldi, G., Jr., J. R. David, and D. McMahon-Pratt. 1987. Identification and distribution of New World Leishmania species characterized by serodeme analysis using monoclonal antibodies. Am. J. Trop. Med. Hyg. 36:270-287.
100. Grimaldi, G., Jr., R. D. Kreutzer, Y. Hashiguchi, E. A. Gomez, T. Mimory, and R. B. Tesh. 1992. Description of Leishmania equatorensis sp.n. (Kinetoplastida: Trypanosomatidae), a new parasite infecting arboreal mammals in Ecuador. Mem. Inst. Oswaldo Cruz 87:221-228.
101. Grimaldi, G., Jr. and D. McMahon-Pratt. 1991. Leishmaniasis and its etiologic agents in the New World: an overview, p. 73-118. In T. Sun (ed.), Progress in Clinical Parasitology, vol. 2. Field & Wood Medical Publishers, Inc., New York.
102. Grimaldi, G., Jr., H. Momen, R. D. Naiff, D. McMahon-Pratt, and T. V. Barrett. 1991. Characterization and classification of leishmanial parasites from humans, wild animals, and sand flies in the Amazon region of Brazil. Am. J. Trop. Med. Hyg. 44:645-661.
103. Grimaldi, G., Jr., R. B. Tesh, and D. McMahon-Pratt. 1989. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am. J. Trop. Med. Hyg. 41:687-725.
104. Grogl, M., R. K. Martin, A. M. J. Oduola, W. K. Milhous, and D. E. Kyle. 1991. Characteristics of multidrug resistance in Plasmodium and Leishmania: detection of P-glycoprotein-like components. Am. J. Trop. Med. Hyg. 45:98-111.
105. Grogl, M., A. M. J. Oduola, L. D. C. Cordero, and D. E. Kyle. 1989. Leishmania ssp.: development of Pentostam-resistant clones in vitro by discontinuous drug exposure. Exp. Parasitol. 69:78-90.
106. Grogl, M., T. N. Thomason, and E. D. Franke. 1992. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am. J. Trop. Med. Hyg. 47:117-126.
107. Guderian, R. H., M. E. Chico, M. D. Rogers, K. M. Pattishall, M. Grogl, and J. D. Berman. 1991. Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis. Am. J. Trop. Med. Hyg. 45:92-97.
108. Gunders, A. E. 1987. Vaccination: past and future role in control, p. 928-941. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. 2. Academic Press, Ltd., London.
109. Gutierrez, Y., G. H. Salinas, G. Palma, L. B. Valderrama, C. V. Santrich, and N. G. Saravia. 1991. Correlation between histopathology, immune response, clinical presentation, and evolution in Leishmania braziliensis infection. Am. J. Trop. Med. Hyg. 45:281-289.
110. Hall, B. F., and K. A. Joiner. 1991. Strategies of obligate intracellular parasites for evading host defences. Immunol. Today 12:A22-A27.
111. Handman, E., R. E. Hocking, G. E. Mitchell, and T. W. Spithill. 1983. Isolation and characterization of infective and noninfective clones of Leishmania tropica. Mol. Biochem. Parasitol. 7:111-126.
112. Handman, E., and G. F. Mitchell. 1985. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proc. Natl. Acad. Sci. USA 82:5910-5914.
113. Handman, E., G. F. Mitchell, and I. W. Goding. 1987. Leishmania major: a very sensitive dot-blot ELISA for detection of parasites in cutaneous lesions. Mol. Biol. Med. 4:377-383.
114. Harith, A. E., A. H. Kolk, P. A. Kager, J. Leeuwenburg, F. J. Faber, R. Muigai, S. Kiugu, and J. J. Laarman. 1987. Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and seroepidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA. Trans. R. Soc. Trop. Med. Hyg. 81:603-606.
115. Harms, G., C. Pedrosa, S. Omena, H. Feldemeier, and K. Zwingenberger. 1991. Natural killer cell activity in visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 85:54-55.
116. Harms, G., K. Zwingenberger, A. K. Chehade, S. Talhari, P. Racz, A. Mouakeh, M. Douba, L. Naekel, R. O. Naiff, P. Kresmner, H. Feldmeier, and U. Bienzle. 1989. Effects of intradermal gamma-interferon in cutaneous leishmaniasis. Lancet i:1287-1292.
117. Hashigushi, Y., E. A. Gomez, V. V. De Coronel, T. Mimori, M. Kawabata, M. Furuya, S. Nonaka, H. Takaoka, J. B. Alexander, A. M. Quizhpe, G. Grimaldi, Jr., R. D. Kreutzer, and R. B. Tesh. 1991. Andean leishmaniasis in Ecuador caused by infection with Leishmania mexicana and L. major-like parasites. Am. J. Trop. Med. Hyg. 44:205-217.
118. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of Interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
119. Hendricks, L. D., D. E. Wood, and M. E. Hadjuk. 1978. Haemoflagellates: commercially available liquid media for rapid cultivation. Parasitology 76:309-316.
120. Herwaldt, B. L., and J. D. Berman. 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am. J. Trop. Med. Hyg. 46:296-303.
121. Heyneman, D. 1971. Immunology of leishmaniasis. Bull. W.H.O. 44:499-514.
122. + T lymphocytes to mediate protective immunity against Leishmania. J. Exp. Med. 169:1819-1827.
123. Hockertz, S., M. Baccarini, and M. L. Lohmann-Matthes. 1989. Functional heterogeneity of macrophage precursor cells from spleen of Leishmania donovani-infected and untreated mice. J. Immunol. 142:2489-2494.
124. Holaday, B. J., M. D. Sadick, and R. D. Pearson. 1988. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani. J. Immunol. 141:2132-2137.
125. Holaday, B. J., M. D. Sadick, Z. E. Wang, S. L. Reiner, F. P. Heinzel, T. G. Parslow, and R. M. Locksley. 1991. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J. Immunol. 147:1653-1658.
126. Howard, M. K., J. M. Kelly, R. P. Lane, and M. M. Miles. 1991. A sensitive repetitive DNA probe that is specific to the Leishmania donovani complex and its use as an epidemiological and diagnostic reagent. Mol. Biochem. Parasitol. 44:62-72.
127. Huang, P. L., B. E. Roberts, D. McMahon-Pratt, J. R. David, and J. S. Miller. 1984. Structure and arrangement of the beta-tubulin genes of Leishmania tropica. Mol. Cell. Biol. 4:1372-1383.
128. Iovannisci, D. M., and S. M. Beverley. 1989. Structural alterations of chromosome 2 in Leishmania major as evidence for diploidy, including spontaneous amplification of the mini-exon array. Mol. Biochem. Parasitol. 34:177-188.
129. Jackson, J. E., J. D. Tally, W. Y. Ellis, Y. B. Mebrahtu, P. G. Lawyer, J. B. Were, S. G. Reed, D. M. Panisko, and B. L. Limmer. 1990. Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy. Am. J. Trop. Med. Hyg. 43:464-480.
130. Jackson, P. R., J. M. Lawrie, J. M. Stiteler, D. N. Hawkins, J. A. Wohlhieter, and E. D. Rowton. 1986. Detection and characterization of Leishmania species and strains from mammals and vectors by hybridization and restriction endonuclease digestion of kinetoplast DNA. Vet. Parasitol. 20:195-215.
131. Jaffe, C. L., and D. McMahon-Pratt. 1987. Serodiagnostic assay for visceral leishmaniasis employing monoclonal antibodies. Trans. R. Soc. Trop. Med. Hyg. 81:587-594.
132. Jaffe, C. L., N. Rachamin, and R. Sarfstein. 1990. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis. J. Immunol. 144:699-706.
133. Jaffe, C. L., and M. Zalis. 1988. Use of purified proteins from Leishmania donovani for the rapid serodiagnosis of visceral leishmaniasis. J. Infect. Dis. 157:1212-1216.
134. Jardim, A., J. Alexander, H. S. Teh, D. W. Ou, and R. W. Olafson. 1990. Immunoprotective Leishmania major synthetic T cell epitopes. J. Exp. Med. 172:645-648.
135. Kapler, G. M., C. M. Coburn, and S. M. Beverley. 1990. Stable transfection of the human parasite Leishmania delineates a 30-kb region sufficient for extrachromosomal replication and expression. Mol. Cell. Biol. 10:1084-1094.
136. Karp, C. L., S. J. Turco, and D. L. Sacks. 1991. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum. J. Immunol. 147:680-684.
137. Katakura, K., and A. Kobayashi. 1988. Acid phosphatase activity of virulent and avirulent clones of Leishmania donovani promastigotes. Infect. Immun. 56:2856-2860.
138. Kaye, P. M., A. J. Curry, and J. M. Blackwell. 1991. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146:2763-2770.
139. Keithly, J. 1989. Ornithine decarboxylase and trypanothione reductase genes in Leishmania braziliensis guyanensis. J. Protozool. 36:498-501.
140. Kennedy, W. P. K. 1984. Novel identification of differences in kinetoplast DNA of Leishmania isolates by recombinant DNA techniques and in situ hybridization. Mol. Biochem. Parasitol. 12:313-325.
141. Kidane, G. Z., N. Samaras, and T. W. Spithill. 1989. Cloning of developmentally regulated genes from Leishmania major and expression following heat induction. J. Biol. Chem. 264:4244-4250.
142. King, D. L., and S. J. Turco. 1988. A ricin agglutinin-resistant clone of Leishmania donovani deficient in lipophosphoglycan. Mol. Biochem. Parasitol. 28:285-294.
143. Kink, J. A., and K.-P. Chang. 1987. Tunicamycin-resistant Leishmania mexicana amazonensis: expression of virulence associated with an increased activity of N-acetylglucosaminyl-transferase and amplification of its presumptive gene. Proc. Natl. Acad. Sci. USA 84:1253-1257.
144. Kirkpatrick, C. E., and J. P. FarrelL 1984. Splenic NK cell activity in mice infected with Leishmania donovani. Cell. Immunol. 85:201-204.
145. Kreutzer, R. D. 1990. Genetic analysis of Leishmania mexicana populations from Texas, Latin America, and the Caribbean. Am. J. Trop. Med. Hyg. 43:367-372.
146. Kreutzer, R. D., A. Corredor, G. Grimaldi, Jr., M. Grogl, E. D. Rowton, D. G. Young, A. Morales, D. McMahon-Pratt, H. Guzman, and R. B. Tesh. 1991. Characterization of Leishmania colombiensis sp.n. (Kinetoplastida: Trypanosomatidae), a new parasite infecting humans, animals, and phlebotomine sand flies in Colombia and Panama. Am. J. Trop. Med. Hyg. 44:662-675.
147. Kreutzer, R. D., N. Souraty, and M. E. Semko. 1987. Biochemical identities and differences among Leishmania species and subspecies. Am. J. Trop. Med. Hyg. 36:22-32.
148. Lainson, R. 1988. Ecological interactions in the transmission of the leishmaniases. Philos. Trans. R. Soc. London 321:389-404.
149. Lainson, R. 1989. Demographic changes and their influence on the epidemiology of the American leishmaniases, p. 85-106. In M. W. Service (ed.), Demography and vector-borne diseases. CRC Press, Boca Raton, Fla.
150. Lainson, R., R. R. Braga, A. A. A. de Souza, M. M. Povoa, E. A. Y. Ishikawa, and F. T. Silveira. 1989. Leishmania (Viannia) shawl sp.n., a parasite of monkeys, sloths and procyonids in Amazonian Brazil. Ann. Parasitol. Hum. Comp. 64:200-207.
151. Lainson, R., and J. J. Shaw. 1979. The role of animals in the epidemiology of the South American leishmaniasis, p. 1-116. In H. R. Lumsden and D. A. Evans (ed.), Biology of the Kinetoplastida, vol. 2. Academic Press Ltd., London.
152. Lainson, R., and J. J. Shaw. 1987. Evolution, classification and geographical distribution, p. 1-120. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. 1. Academic Press Ltd., London.
153. Lainson, R., and J. J. Shaw. 1989. Leishmania (Viannia) naiffi sp.n., a parasite of the armadillo, Dasypus novemcinctus (L.), in Amazonian Brazil. Ann. Parasitol. Hum. Comp. 64:3-9.
154. Lainson, R., J. J. Shaw, F. T. Silveira, R. R. Braga, and E. A. Y. Ishikawa. 1990. Cutaneous leishmaniasis of man due to Leishmania (Viannia) naiffi Lainson and Shaw, 1989. Ann. Parasitol. Hum. Comp. 65:282-284.
155. Lainson, R., J. J. Shaw, A. A. A. Souza, F. T. Silveira, and A. Falqueto. Further observations on Lutzomyia ubiquitalis (Psychodidae:Phlebotomine), the sandfly vector of Leishmania (Viannia) lainsoni. Mem. Inst. Oswaldo Cruz, in press.
156. Lago, L., J. B. Vieira, J. L. M. Costa, and P. D. Marsden. 1990. Prevalence of mucocutaneous leishmaniasis in littoral Bahia, Brazil. Trans. R. Soc. Trop. Med. Hyg. 84:241.
157. Landfear, S. M., D. McMahon-Pratt, and D. F. Wirth. 1983. Tandem arrangement of tubulin genes in the protozoan parasite Leishmania enriettii. Mol. Cell. Biol. 3:1070-1076.
158. Lanotte, G., and J. A. Rioux. 1990. Fusion cellulaire chez les Leishmania (Kinetoplastia, Trypanosomatidae). C.R. Acad. Sci. Paris Ser. III 310:285-288.
159. Laskay, T., T. Gemetchu, H. Teferedegn, and D. Frommel. 1991. The use of DNA hybridization for the detection of Leishmania aethiopica in naturally infected sandfly vectors. Trans. R. Soc. Trop. Med. Hyg. 85:599-602.
160. LeBowitz, J. H., C. M. Coburn, D. McMahon-Pratt, and S. M. Beveley. 1990. Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes. Proc. Natl. Acad. Sci. USA 87:9736-9740.
161. Lee, M. G. S., B. L. Atkinson, S. H. Giannini, and L. H. T. Van der Ploeg. 1988. Structure and expression of the HSP70 gene family of Leishmania major. Nucleic Acids Res. 16:9567-9585.
162. Leon, L. L., G. M. C. Machado, L. E. Carvalho Paes, and G. Grimaldi, Jr. 1990. Antigenic differences of Leishmania amazonensis isolates causing diffuse cutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 84:678-680.
163. Leon, W., D. L. Fouts, and J. Manning. 1978. Sequence arrangement of the 16S and 26S rRNA genes in the pathogenic haemoflagellate Leishmania donovani. Nucleic Acids Res. 5:491-503.
164. Lerner, E. A., J. M. C. Ribeiro, R. J. Nelson, and M. R. Lerner. 1991. Isolation of Maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. J. Biol. Chem. 266:11234-11236.
165. Lewis, D. J., D. G. Young, G. B. Fairchild, and D. M. Minter, 1977. Proposals for a stable classification of the phlebotomine sandflies (Diptera: Psychodidae). Syst. Entomol. 2:319-332.
166. Liew, F. Y. 1987. Analysis of host-protective and disease-promoting T cells. Ann. Inst. Pasteur/Immunol. (Paris) 138: 749-755.
167. Liew, F. Y., and F. E. G. Cox. 1991. Nonspecific defense mechanism: the role of nitric oxide. Immunoparasitol. Today 12(3)/7(3):A17-A21.
168. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide J Immunol. 145:4306-4310.
169. Liew, F. Y., S. Millott, C. Parkinson, R. M. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol 144:4794-4797.
170. Liew, F. Y., S. Millott, and J. A. Schmidt. 1990. A repetitive peptide of Leishmania can activate T helper type 2 cells and enhance disease progression. J. Exp. Med. 172:1359-1365.
171. Locksley, R. M., F. P. Heinzel, M. D. Sadick, B. J. Holaday, and K. D. Gardener. 1987. Murine cutaneous leishmaniasis: Susceptibility correlates with differential expansion of helper T-cell subsets. Ann. Inst. Pasteur/Immunol. (Paris) 138:744-749.
172. Locksley, R. M., and P. Scott. 1991. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Irnmunoparasitol. Today 12(3)/7(3):A54-A58.
173. Lohman, K. L., P. J. Langer, and D. McMahon-Pratt. 1990. Molecular cloning and characterization of the immunologically protective surface glycoprotein GP46/M-2 of Leishmania amazonensis. Proc. Natl. Acad. Sci. USA 87:8393-5397.
174. Lopes, U. G., and D. F. Wirth. 1986. Identification of visceral Leishmania species with cloned sequences of kinetoplast DNA. Mol. Biochem. Parasitol. 20:308-314.
175. Lopez, J. A., H. A. Reins, R. J. Etges, L. L. Button, W. R. McMaster, P. Overath, and J. Klein. 1991. Genetic control of the immune response in mice to Leishmania mexicana surface protease. J. Immunol. 146:1328-1334.
176. Lopez, M., C. Orrego, M. Cangalaya, R. Inga, and J. Arevalo. In vitro amplification of a kinetoplast DNA sequence to detect Leishmania parasites in biopsies. Biotechnology, in press.
177. Lortholary, D., D. Mechali, D. Christiaens, M. G. Pocidalo, M. Bradely, and P. Babinet. 1990. Interferon gamma associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS. Rev. Infect. Dis. 12:370-371.
178. Lynch, N. R., C. Malave, R. Benito Ifante, R. L. Modlin, and J. Convit. 1986. In situ detection of amastigotes in American cutaneous leishmaniasis, using monoclonal antibodies. Trans. R. Soc. Trop. Med. Hyg. 80:6-9.
179. Machado, E. S., M. P. Braga, A. M. da Cruz, S. G. Coutinho, A. R. M. Vieira, M. S. Rutowitsch, T. Cuzzi-Maya, G. Grimaldi, Jr., and J. A. Menezes. 1992. Disseminated American mucocutaneous leishmaniasis caused by Leishmania braziliensis in a patient with HIV infection: a case report. Mem. Inst. Oswalde Cruz 87:487-492.
180. Manson-Bahr, P. E. C. 1987. Diagnosis, p. 709-729. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. 2. Clinical aspects and control. Academic Press, Inc., New York.
181. Marchand, M., S. Daoud, and R. G. Titus. 1987. Variants with reduced virulence derived from Leishmania major after mutagen treatment. Parasitol. Immunol. 9:81-92.
182. Marsden, P. D., and T. C. Jones. 1985. Clinical manifestations, diagnosis and treatment of leishmaniasis, p. 183-198. In K.-P. Chang and R. S. Bray (ed.), Leishmaniasis. Elsevier, London.
183. Martinez, S., D. L. Looker, R. L. Berens, and J. J. Marr. 1988. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis. Am. J. Trop. Med. Hyg. 39:250-255.
184. Martinez, S., and J. J. Marr. 1992. Allopurinol in the treatment of American cutaneous leishmaniasis. N. Engl. J. Med. 326: 741-744.
185. Massamba, N. N., and M. J. Mutinga. 1992. Recombinant kinetoplast DNA (kDNA) probe for identifying Leishmania tropica. Acta Trop. 52:1-15.
186. Mauel, J., and R. Behin. 1987. Immunity: clinical and experimental, p. 731-791. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. 2. Academic Press Ltd., London.
187. Mayrink, W., C. A. Costa, P. A. Magalhaes, M. N. Melo, M. Dias, A. Oliveira Lima, M. S. Michalick, and P. Williams. 1979. A field trial of a vaccine against American dermal leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 73:385-387.
188. Mayrink, W., P. Williams, C. A. Costa, P. A. Magalhae, M. N. Melo, M. Dias, A. Oliveira Lima, M. S. M. Michalick, E. F. Carvalho, G. C. Barros, P. A. Sessa, and T. A. Alencar. 1985. An experimental vaccine against American dermal leishmaniasis: experience in the State of Espirito Santo, Brazil. Ann. Trop. Med. Parasitol. 79:259-269.
189. McConville, M. J., A. Bacic, G. F. Mitchell, and E. Handman. 1987. Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor. Proc. Natl. Acad. Sci. USA 84:8941-8952.
190. McElrath, M. J., H. W. Murray, and Z. A. Cohn. 1988. The dynamics of granuloma formation in experimental visceral leishmaniasis. J. Exp. Med. 167:1927-1937.
191. McNeely, T. B., G. Rosen, M. V. Londner, and S. J. Turco. 1989. Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania. Biochem. J. 259:601-604.
192. Mebrahtu, Y., P. Lawyer, J. Githure, J. B. Were, R. Muigai, L. Hendricks, J. Leeuwenburg, D. Koech, and C. Roberts. 1989. Visceral leishmaniasis unresponsive to Pentostam caused by Leishmania tropica in Kenya. Am. J. Trop. Med. Hyg. 41:289-294.
193. Mendonca, S. C., S. G. Coutinho, R. R. Amendoeira, M. C. A. Marzochi, and C. Pirmez. 1986. Human American cutaneous leishmaniasis (Leishmania b. braziliensis) in Brazil: lymphoproliferative responses and influence of therapy. Clin. Exp. Immunol. 64:269-276.
194. Mendonca, S. C. F., D. G. Russell, and S. G. Coutinho. 1991. Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63). Clin. Exp. Immunol. 83:472-478.
195. Mendonca, S. C. F., D. G. Russell, T. G. Restom, and S. G. Coutinho. 1990. Human T cell proliferative responses to Leishmania braziliensis lipophosphoglycan: fact or artefact? J. Immunol. Immunopharmacol. 10:188-189.
196. Mengistu, G., H. Akuffo, T. E. Fehniger, Y. Nagese, and R. Nilsen. 1992. Comparison of parasitological and immunological methods in the diagnosis of leishmaniasis in Ethiopia. Trans. R. Soc. Trop. Med. Hyg. 86:154-157.
197. Mengistu, G., R. Kiessling, and H. Akuffo. 1990. The value of a direct agglutination test in the diagnosis of cutaneous and visceral leishmaniasis in Ethiopia. Trans. R. Soc. Trop. Med. Hyg. 84:359-362.
198. Miller, S. I., S. M. Landfear, and D. F. Wirth. 1986. Cloning and characterization of a Leishmania enriettii gene encoding an RNA spliced leader sequence. Nucleic Acids 14:7341-7360.
199. Mirkovich, A. M., A. Galelli, A. C. Allison, and F. Z. Modabber. 1986. Increased myelopoiesis during L. major infection in mice: generation of "safe targets," a possible way to evade the effector immune mechanism. Clin. Exp. Immunol. 64:1-7.
200. Modlin, R. L., C. Pirmez, F. M. Hofman, V. Torigian, K. Uyemura, T. H. Rea, B. R. Bloom, and M. B. Brenner. 1989. Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature (London) 339:544-548.
201. Momen, H., and G. Grimaldi, Jr. 1984. On the identity of Leishmania mexicana pifanoi and L. mexicana garnhami. Trans. R. Soc. Trop. Med. Hyg. 78:701-702.
202. Momen, H., and G. Grimaldi, Jr. 1989. Enzyme electrophoretic evidence for the importation of L. infantum into the New World, p. 911-916. In D. T. Hart (ed.), Leishmaniasis. Plenum Publishing Co., New York.
203. Momen, H., G. Grimaldi, Jr., R. S. Pacheco, C. L. Jaffe, D. McMahon-Pratt, and M. C. A. Marzochi. 1985. Brazilian Leishmania stocks phenotypically similar to Leishmania major. Am. Trop. Med. Hyg. 34:1076-1084.
204. Montalban, C., R. Martinez-Fernandez, J. L. Calleja, J. D. Garcia-Diaz, R. Rubio, F. Dronda, S. Moreno, M. Yebra, C. Barros, J. Cobo, M. C. Martinez, F. Ruiz, and J. R. Costa. 1989. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev. Infect. Dis. 11:655-660.
205. Mosmann, T. R., and K. W. Moore. 1991. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol. Today 12:A49-A53.
206. Mukhopadhyay, A., G. Chaudhuri, S. K. Arora, S. Seghal, and S. K. Basu. 1989. Receptor-mediated drug delivery to macrophages in chemotherapy of leishmaniasis. Science 244:705-707.
207. Munoz, E., A. M. Zubiaga, M. Merrow, N. P. Sauter, and B. T. Huber. 1990. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172:95-103.
208. Murray, H. W., J. D. Berman, and S. D. Wright. 1988. Immunohemotherapy for intracellular Leishmania donovani infection: gamma Interferon plus pentavalent antimony. J. Infect. Dis. 157:973-974.
209. Murray, H. W., B. Y. Rubin, S. Carriero, and A. M. Acosta. 1984. Reversible defect in antigen-induced lymphokine and gamma interferon generation in cutaneous leishmaniasis. J. Immunol. 133:2250-2254.
210. Murray, P. J., E. Handman, T. A. Glaser, and T. W. Spithill. 1990. Leishmania major: expression and gene structure of the glycoprotein 63 molecule in virulent and avirulent clones and strains. Exp. Parasitol. 71:294-306.
211. Musumeci, S., G. Schiliro, S. Li Volti, and A. Sciotto. 1980. Lymphocyte changes in Mediterranean kala-azar. Trans. R. Soc. Trop. Med. Hyg. 75:304-305.
212. Naiff, R. D., R. A. Freitas, M. F. Naiff, J. R. Arias, T. V. Barrett, H. Momen, and G. Grimaldi, Jr. 1991. Epidemiological and nosological aspects of L. naiffi Lainson & Shaw, 1989. Mem. Inst. Oswaldo Cruz 86:317-321.
213. Naiff, R. D., S. Talhari, and T. V. Barrett. 1988. Isolation of Leishmania guyanensis from lesions of the nasal mucosa. Mem. Inst. Oswaldo Cruz 83:529-530.
214. Navin, T. R., B. A. Arana, F. E. Arana, J. D. Berman, and J. F. Chajon. 1992. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) vs. ketoconazole for treating cutaneous leishmaniasis in Guatemala. J. Infect. Dis. 165:528-534.
215. Navin, T. R., B. A. Arana, F. E. Arana, A. M. Merida, A. L. Castillo, and J. L. Pozuelos. 1990. Placebo-controlled clinical trial of Meglumine antimoniate (Glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am. J. Trop. Med. Hyg. 42:43-50.
216. Navin, T. R., F. E. Arana, A. M. Merida, B. A. Arana, A. L. Castillo, and D. N. Silvers. 1990. Cutaneous leishmaniasis in Guatemala: comparison of diagnostic methods. Am. J. Trop. Med. Hyg. 42:36-42.
217. Neal, R. A. 1987. Experimental chemotherapy, p. 793-846. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. 2. Academic Press Ltd., London.
218. Netto, E. M., P. D. Marsden, E. A. Llanos-Cuentas, J. M. L. Costa, C. C. Cuba, A. C. Barreto, R. Badaro, W. D. Johnson, and T. C. Jones. 1990. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime. Trans. R. Soc. Trop. Med. Hyg. 84:367-370.
219. Nicodemo, E. L., M. I. S. Duarte, C. E. P. Corbett, A. C. Nicodemo, V. L. R. Matta, R. Chebabo, and V. Amato Neto. 1990. Visceral leishmaniases in AIDS patient. Rev. Inst. Med. Trop. Med. Sao Paulo 32:310-311.
220. Oliveira Neto, M. P., G. Grimaldi, Jr., H. Momen, R. S. Pacheco, M. C. A. Marzochi, and D. McMahon-Pratt. 1986. Active cutaneous leishmaniasis in Brazil, induced by Leishmania donovani chagasi. Mem. Inst. Oswaldo Cruz 81:303-309.
221. Oliveira Neto, M. P., M. C. A. Marzochi, G. Grimaldi, Jr., R. S. Pacheco, L. M. Toledo, and H. Momen. 1986. Concurrent human infection with Leishmania donovani and L. braziliensis braziliensis. Ann. Trop. Med. Parasitol. 80:587-592.
222. Pages, M., P. Bastien, F. Veas, V. Rossi, M. Belli, P. Wincker, J.-A. Rioux, and G. Roizes. 1989. Chromosome size and number polymorphisms in Leishmania infantum suggest amplification/deletion and possible genetic exchange. Mol. Biochem. Parasitol. 36:161-168.
223. Palma, G. and Y. Gutierrez. 1991. Laboratory diagnosis of Leishmania. Clin. Lab. Med. 11:909-922.
224. Pan, A. A. 1984. Leishmania mexicana: serial cultivation of intracellular stages in a cell free medium. Exp. Parasitol. 58:72-80.
225. Pearson, R. D., T. Evans, and D. A. Wheeler. 1986. Humoral factors during South American visceral leishmaniasis. Am. J. Trop. Med. Hyg. 80:465-468.
226. Perez, J. E., P. Villaseca, A. Caceres, M. Lopez, A. Zolessi, M. Campos, H. Guerra, and A. Llanos-Cuentas. 1991. Leishmania (Viannia) peruviana isolated from the sandfly Lutzomyia peruensis (Diptera: Psychodidae) and a sentinel hamster in the Huayllacallan Valley, Ancash, Peru. Trans. R. Soc. Trop. Med. Hyg. 85:60.
227. Pessoa, S. B. 1941. Segunda nota sobre a vacinacao preventiva na leishmaniose tegumentar americana com leptomonas mortas. Rev. Paul. Med. 19:1-9.
228. Peters, B. S., D. Fish, R. Golden, D. A. Evans, A. D. Bryceson, and A. J. Pinching. 1990. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q. J. Med. 77:1101-1111.
229. Peters, W., S. Elbihari, and D. A. Evans. 1986. Leishmania infecting man and wild animals in Saudi Arabia. 2. Leishmania arabica n. sp. Trans. R. Soc. Trop. Med. Hyg. 80:497-502.
230. Peterson, E. A., F. A. Neva, A. Barral, R. Correa-Coronas, H. Bogaertz-Diaz, D. Martinez, and F. E. Ward. 1984. Monocyte suppression of antigen-specific lymphocyte responses in diffuse cutaneous leishmaniasis patients from the Dominican Republic. J. Immunol. 132:2603-2606.
231. Pialoux, G., C. Hennequin, B. Dupont, and P. Ravisse. 1990. Cutaneous leishmaniasis in an AIDS patient: cure with itraconizole. J. Infect. Dis. 162:1221-1222.
232. Pirmez, C., C. Cooper, M. Paes-Oliveira, A. Schubach, V. K. Torigian, and R. L. Modlin. 1990. Immunologic responsiveness in American cutaneous leishmaniasis lesions. J. Immunol. 145:3100-3104.
233. Ponce, C., E. Ponce, A. Morrison, A. Cruz, R. Kreutzer, D. McMahon-Pratt, and F. Neva. 1991. Leishmania donovani chagasi: new clinical variant of cutaneous leishmaniasis in Honduras. Lancet 337:67-70.
234. Preston, P. M. 1987. The immunology, immunopathology, and immunoprophylaxix of Leishmania infections, p. 119-181. In E. J. L. Soulsby (ed.), Immune responses in parasitic infections: immunology, immunopathology, and immunoprophylaxis, vol. 3. Protozoa. CRC Press, Boca Raton, Fla.
235. Rabinovitch, M. 1989. Leishmaniacidal activity of amino acid and peptide esters. Parasitol. Today 5:299-301.
236. Ready, P. D., H. Fraiha, R. Lainson, and J. J. Shaw. 1980. Psychocopygus as a genus: reasons for a flexible classification of the phlebotomine sand flies (Diptera: Psychodidae). J. Med. Entomol. 17:75-88.
237. Ready, P. D., D. F. Smith, and R. Killick-Kendrick. 1988. DNA hybridizations on squash-blotted sandflies to identify both Phlebotomus papatasi and infecting Leishmania major. Med. Vet. Entomol. 2:109-116.
238. Reed, S. G., R. Badaro, and R. M. Cheri-Lloyd. 1987. Identification of specific and cross-reactive antigens of Leishmania donovani chagasi recognized by human infection sera. J. Immunol. 126:1614-1618.
239. Reed, S. G., R. Badaro, N. Masur, E. Carvalho, R. Lorenco, A. Lisboa, R. Teixeira, W. R. Johnson, Jr., and T. C. Jones. 1986. Selection of a skin test antigen for American visceral leishmaniasis. Am. J. Trop. Med. Hyg. 35:79-85.
240. Reed, S. G., E. M. Carvalho, C. H. Sherbert, D. P. Sampaio, D. M. Russo, O. Bacelar, D. L. Pihl, J. M. Scott, A. Barrai, K. H. Grabstein, and W. D. Johnson, Jr. 1990. In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease. J. Clin. Invest. 85:690-696.
241. Reed, S. G., W. G. Shreffler, J. M. Burns, Jr., J. M. Scott, M. G. Orge, H. W. Ghalib, M. Siddig, and R. Badaro. 1990. An improved serodiagnostic procedure for visceral leishmaniasis. Am. J. Trop. Med. Hyg. 43:632-639.
242. Rees, P. H., and P. A. Kager. 1987. Visceral leishmaniasis and post-kala-azar dermal leishmaniasis, p. 583-616. In W. Peters, and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine vol. 2. Academic Press, Inc., New York.
243. Reiner, N. E. 1987. Parasite-accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani. J. Immunol. 138:1919-1925.
244. Reiner, N. E., N. G. Winnie, and W. R. McMaster. 1987. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex products J. Immunol. 138:1926-1932.
245. Revollo, S., L. Dimier-David, C. David, P. Lyevre, C. Camancho, and J. P. Dedet. 1992. Isoenzyme characterization of Leishmania braziliensis braziliensis isolates obtained from Bolivian and Peruvian patients. Trans. R. Soc. Trop. Med. Hyg. 86:388-391.
246. Rezai, J. R., S. M. Ardehali, G. Amirhakimi, and A. Kharazmi. 1978. Immunological features of kala-azar. Am. J. Trop. Med Hyg. 27:1079-1083.
247. Ribeiro, J. M. C. 1989. Vector salavia and its role in parasite transmission. Exp. Parasitol. 69:104-106.
248. Ridley, D. S. 1980. A histological classification of cutaneous leishmaniasis and its geographical distribution. Trans. R. Soc. Trop. Med. Hyg. 74:515-521.
249. Ridley, D. S. 1987. Pathology, p. 666-701. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. 2. Academic Press Ltd., London.
250. Ridley, D. S., P. D. Marsden, C. C. Cuca, and A. C. Barreto. 1980. A histological classification of mucocutaneous leismaniasis in Brazil and its clinical evaluation. Trans. R. Soc. Trop. Med. Hyg. 74:508-514.
251. Rioux, J.-A. 1986. Leishmania: taxonomie et phylogenesc. Applications eco-epidemiologiques. Institut Mediterraneen d'Etudes Epidemiologiques et Ecologiques, Montpellier, France.
252. Rioux, J.-A., G. Lanotte, E. Serres, F. Pratlong, P. Bastien, and J. Perieres. 1990. Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann. Parasitol. Hum. Comp. 65:111-125.
253. Rocha, R. A., R. N. Sampaio, M. Guerra, A. Magalhaes, C. C. Cuba, A. C. Barreto, and P. D. Marsden. 1980. Apparent glucantime failure in five patients with mucocutaneous leishmaniasis. J. Trop. Med. Hyg. 83:131-139.
254. Rodgers, M. R., S. J. Popper, and D. F. Wirth. 1990. Amplification of kinetoplast DNA as a tool in the detection and diagnosis of Leishmania. Exp. Parasitol. 71:267-275.
255. Rodrigues Coura, J., B. Galvao Castro, and G. Grimaldi, Jr. 1987. Dissiminated American cutaneous leishmaniasis in a patient with AIDS. Mem. Inst. Oswaldo Cruz 82:581-582.
256. Rogers, W., P. F. Burnheim, and D. F. Wirth. 1988. Detection of Leishmania within sand flies by kinetoplast DNA hybridization. Am. J. Trop. Med. Hyg. 39:434-439.
257. H2 subsets: doubt no more. Immunol. Today 12:256-257.
258. Romero, G. G., M. Arana, M. Lopez, I. Montoya, R. Bohl, M. Campos, J. Arevalo, and A. Llanos. 1987. Characterization of Leishmania species from Peru. Trans. R. Soc. Trop. Med. Hyg. 81:14-24.
259. Rossell, R. A. de, R. de J. de Duran, O. Rossell, and A. M. Rodriguez. 1992. Is leishmaniasis ever cured? Trans. R. Soc. Trop. Med. Hyg. 86:251-253.
260. Russel, D. G., and J. Alexander. 1988. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 140:1274.
261. Russo, D. M., J. M. Burns, Jr., E. M. Carvalho, R. J. Armitage, K. H. Grabstein, L. L. Button, W. R. McMaster, and S. G. Reed. 1991. Human T cell responses to gp63, a surface antigen of Leishmania. J. Immunol. 147:3575-3580.
262. Russo, D. M., S. J. Turco, J. M. Burns, Jr., and S. G. Reed. 1992. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. J. Immunol. 148:202-207.
263. Ryan, L., R. Lainson, J. J. Shaw, R. R. Braga, and E. A. Y. Ishikawa. 1987. Leishmaniasis in Brazil. XXV. Sandfly vectors of Leishmania in Para State, Brazil. Med. Vet. Entomol. 1:383-395.
264. Sacci, J. B., H. A. Christensen, A. Vasquez, and R. L. Anthony. 1987. Serodiagnosis of New World leishmaniasis by using a genus-specific antigen in enzyme linked immunosorbent assays. Diagn. Microbiol. Infect. Dis. 6:229-238.
265. Sacks, D. L. 1989. Metacyclogenesis in Leishmania promastigotes. Exp. Parasitol. 69:100-103.
266. Sacks, D. L., and R. P. Da Silva. 1987. The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid. J. Immunol. 139:3099-3106.
267. Sacks, D. L., S. Hieny, and A. Sher. 1985. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135:564-569.
268. Sacks, D. L., S. Lata Lal, S. N. Shrivastava, J. Blackwell, and F. A. Neva. 1987. An analysis of T cell responsiveness in Indian kala-azar. J. Immunol. 138:908-913.
269. Sacks, D. L., and P. Perkins. 1984. Identification of an infective stage of Leishmania promastigotes. Science 223:1417-1419.
270. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 171:115-127.
271. + T cells. J. Immunol. 139:1303-1309.
272. Saenz, R. E., H. Paz, and J. D. Berman. 1990. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am. J. Med. 89:147-155.
273. Saenz, R. E., C. G. Rodriguez, C. M. Johnson, and J. D. Berman. 1991. Efficacy and toxicity of Pentostam against Panamanian mucosal leishmaniasis. Am. J. Trop. Med. Hyg. 44:394-398.
274. Salinas, G., L. Valderrama, G. Palma, G. Montes, and N. G. Saravia. 1989. Deteccion de amstigotas en leishmaniasis cutanea y mucocutanea por el metodo de inmunoperoxidasa, usando anticuerpo policlonal: sensibilidad y especificidad comparadas con metodos convencionales de diagnostico. Mem. Inst. Oswaldo Cruz 84:53-60.
275. Samaras, N., and T. W. Spithill. 1987. Molecular karyotype of five species of Leishmania and analysis of gene locations and chromosomal rearrangements. Mol. Biochem. Parasitol. 25: 279-291.
276. Samuelson, J., E. Lerner, R. Tesh, and R. Titus. 1991. A mouse model of Leishmania braziliensis braziliensis infection produced by co-injection with sand fly saliva. J. Exp. Med. 173:49-54.
277. Santrich, C., I. Segura, A. L. Arias, and N. G. Saravia. 1990. Mucosal disease caused by Leishmania braziliensis guyanensis. Am. J. Trop. Med. Hyg. 42:51-55.
278. Saravia, N. G., A. F. Holguin, D. McMahon-Pratt, and A. D'Alessandro. 1985. Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. Am. J. Trop. Med. Hyg. 34:714-720.
279. Saravia, N. G., K. Weigle, I. Segura, S. H. Giannini, R. Pacheco, L. A. Labrada, and A. Goncalves. 1990. Recurrent lesions in human Leishmania braziliensis infection-reactivation or reinfection? Lancet 336:398-402.
280. Scaglia, M., M. Villa, S. Gatti, and F. Fabio. 1989. Cutaneous leishmaniasis in acquired immunodeficiency syndrome. Trans. R. Soc. Trop. Med. Hyg. 83:338-339.
281. Schlein, Y., R. L. Jacobson, and G. Messer. 1992. Leishmania infections damage the feeding mechanism of the sandfly vector and implement parasite transmission by bite. Proc. Natl. Acad. Sci. USA 89:9944-9948.
282. Scholler, J. K., S. Reed, and K. Stuart. 1986. Molecular karyotype of species and subspecies of Leishmania. Mol. Biochem. Parasitol. 20:279-293.
283. Scott, J. M., W. G. Shreffler, H. W. Ghalib. 1991. A rapid and simple diagnostic test for active visceral leishmaniasis. Am. J. Trop. Med. Hyg. 44:272-277.
284. Scott, P. A., P. Caspar, and A. Sher. 1990. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes. J. Immunol. 144:1075-1079.
285. Scott, P. A., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675-1684.
286. Shapira, M., and E. Pinelli. 1989. Heat shock protein 83 of Leishmania mexicana amazonensis is an abundant cytoplasmic protein with a tandemly repeated genomic arrangement. Eur. J. Biochem. 185:231-236.
287. Shaw, J. J., E. A. Y. Ishikawa, R. Lainson, R. R. Braga, and F. T. Silveira. 1991. Cutaneous leishmaniasis of man due to Leishmania (Viannia) shawi Lainson, de Souza, Povoa, Ishikawa & Silveira, in Para State, Brazil. Ann. Parasitol. Hum. Comp. 66:243-246.
288. Silveira, F. T., R. Lainson, J. J. Shaw, R. R. Braga, E. E. A. Ishikawa, and A. A. A. Souza. 1991. Leishmaniose cutanea na Amazonia: isolamento de Leishmania (Vannia) lainsoni do roedor Agouti paca (Rodentia: Dasyproctidae), no Estado do Para, Brasil. Rev. Inst. Med. Trop. Sao Paulo 33:18-22.
289. Silveira, F. T., R. Lainson, J. J. Shaw, and R. S. M. Ribeiro. 1984. Leishmaniose cutanea na Amazonia. Registro do primeiro caso humano de infeccao mista determinada por duas especies distintas de Leishmania: L. braziliensis braziliensis e L. mexicana amazonensis. Rev. Inst. Med. Trop. Sao Paulo 26:272-275.
290. Silveira, F. T., J. J. Shaw, R. R. Braga, and E. Ishikawa. 1987. Dermal leishmaniasis in the Amazon region of Brazil: Leishmania (Viannaia) lainsoni sp.n., a new parasite from the State of Para. Mem. Inst. Oswaldo Cruz 82:289-292.
291. Simpson, L. 1987. The mitochondrial genome of kinetoplastid protozoa: genomic organization, transcription, replication, and evolution. Annu. Rev. Microbiol. 41:363-382.
292. + cytotoxic T cells and Leishmaniainfected macrophages. J. Exp. Med. 174:499-505.
293. Smyth, A. J. S., A. Ghosh, M. Q. Hassan, D. Basu, M. H. L. de Bruijn, S. Adhya, K. K. Mallik, and D. C. Barker. 1992. Rapid and sensitive detection of Leishmania kinetoplast DNA from spleen and blood samples of kala-azar patients. Parasitology 105:183-192.
294. Squires, K. E., R. D. Schreiber, M. J. McElrath, B. Y. Rubin, S. L. Anderson, and H. W. Murray. 1989. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. J. Immunol. 143: 4244-4249.
295. Thakur, C. P., M. Kumar, and A. K. Pandey. 1991. Comparison of regimens of treatment of antimony-resistant kala-azar patients: a randomized study. Am. J. Trop. Med. Hyg. 45:435-441.
296. Theodor, O. 1965. On the classification of American Phlebotominae. J. Med. Entomol. 2:171-197.
297. Theodos, C. M., Y.-H. Nong, H. G. Remold, and R. G. Titus. Salivary gland material from the sand fly Lutzomyia longipalpis has an inhibitory effect on macrophage function in vitro. Parasite Immunol., in press.
298. Titus, R. G., G. C. Lima, H. D. Engers, and J. A. Louis. 1984. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T-cell populations capable of mediating L. major specific delayed type hypersensitivity. J. Immunol. 133:1594-1600.
299. Titus, R. G., G. Milon, G. Marchal, P. Vassali, J.-C. Cerottini, and J. A. Louis. 1987. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur. J. Immunol. 17:1429-1433.
300. Titus, R. G., and J. M. C. Ribeiro. 1988. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 239:1306-1308.
301. Towbin, H., G. Rosenfelder, J. Wieslander, J. L. Avila, M. Rojas, A. Szarfman, K. Esser, H. Nowack, and R. Timpl. 1987. Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl (alpha 1-3)-galactose epitopes. J. Exp. Med. 166:419-132.
302. Travi, B. L., I. D. Velez, L. Brutus, I. Segura, C. Jaramillo, and J. Montoya. 1990. Lutzomyia evansi, an alternate vector of Leishmania chagasi in a Colombian focus of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 84:676-677.
303. Van Eys, G. J. J. M., G. J. Schoone, N. C. M. Kroon, and S. B. Ebeling. 1992. Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Mol. Biochem. Parasitol. 51:133-142.
304. Vioukov, V. N. 1987. Control of transmission, p. 908-928. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. 2. Academic Press Ltd., London.
305. Walters, L. L. 1993. Leishmania differentiation in natural and unnatural sand fly hosts. J. Euk. Microbiol. 40:196-206.
306. Walters, L. L., G. L. Chaplin, G. B. Modi, and R. B. Tesh. 1989. Ultrastructural biology of Leishmania (Viannia) panamensis (= Leishmania brazilziliensis braziliensis) in Lutzomyia gomezi (Diptera: Psychodidae): a natural host-parasite association. Am. J. Trop. Med. Hyg. 40:19-39.
307. Walters, L. L., K. P. Irons, H. Guzman, and R. B. Tesh. 1993. Formation and composition of the peritrophic membrane in the sand fly, Phlebotomus pemiciosus. J. Med. Entomol. 30:179-198.
308. Walters, L. L., K. P. Irons, G. B. Modi, and R. B. Tesh. 1992. Refractory barriers in the sand fly Phlebotomus papatasi (Diptera: Psychodidae) to infection with Leishmania panamensis. Am. J. Trop. Med. Hyg. 46:211-228.
309. Walters, L. L., G. B. Modi, G. L. Chaplin, and R. B. Tesh. 1989. Ultrastructural development of Leishmania chagasi in its vector, Lutzomyia longipalpis (Diptera: Psychodidae). Am. J. Trop. Med. Hyg. 41:295-317.
310. Walters, L. L., G. B. Modi, R. B. Tesh, and T. Burrage. 1987. Host-parasite relationship of Leishmania mexicana mexicana and Lutzomyia abonenci (Diptera: Psychodidae). Am. J. Trop. Med. Hyg. 36:294-314.
311. Walton, B. C. 1970. The indirect fluorescent antibody test for evaluation of effectiveness of chemotherapy in American leishmaniasis. J. Parasitol. 56(Sect. II):480.
312. Walton, B. C. 1987. American cutaneous leishmaniasis, p. 637-664. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. 2. Academic Press Ltd., London.
313. Walton, B. C., R. W. Intermill, and M. E. Hajduk. 1977. Differences in biological characteristics of three Leishmania isolates from patients with espundia. Am. J. Trop. Med. Hyg. 26:850-855.
314. Walton, B. C., and L. C. Valverde. 1979. Racial differences in espundia. Ann. Trop. Med. Parasitol. 73:23-29.
315. Ward, R. D. 1985. Vector biology and control, p. 199-212. In K.-P. Chang and R. S. Bray (ed.), Leishmaniasis. Elsevier, London.
316. Weigle, K. A., L. Valderrama, A. L. Arias, C. Santrich, and N. G. Saravia. 1991. Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. Am. J. Trop. Med. Hyg. 44:260-271.
317. White, A. C., Jr., M. Castes, L. Garcia, D. Trujillo, and L. Zambrano. 1992. Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection. Am J. Trop. Med. Hyg. 46:123-131.
318. Wilson, S. M., R. McNerney, M. B. Moreno, I. Frame, and M. A. Miles. 1992. Adaptation of a radioactive L. donovani complex DNA probe to a chemiluminescent detection system gives enhanced sensitivity for diagnostic and epidemiological applications. Parasitology 104:421-426.
319. Wirth, D. F., and D. McMahon-Pratt. 1982. Rapid identification of Leishmania species by specific hybridization of kinetoplast DNA in cutaneous lesions. Proc. Natl. Acad. Sci. USA 79:6999-7003.
320. Wirth, D. F., W. O. Rogers, R. Barker, H. Dourado, L. Suesebang, and B. Albuquerque. 1986. Leishmaniasis and malaria: new tools for epidemiologic analysis. Science 234:975-979.
321. World Health Organization. 1982. Report of the Informal Meeting on the
322. World Health Organization. 1991. Tropical diseases. Progress in research, 1989-1990, p. 79-87. In TDR Tenth Programme Report. World Health Organization, Geneva.
323. World Health Organization Expert Committee. 1990. Control of the leishmaniases. Tech. Rep. Ser. 793. World Health Organization, Geneva.
324. Yang, D. M., N. Fairweather, L. L. Button, W. R. McMaster, L. P. Kahl, and F. Y. Liew. 1990. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J. Immunol. 145:2281-2289.
325. Young, D. G., and J. R. Arias. 1991. Phlebotomine sandflies of the Americas. Tech. Paper 33. Pan American Health Organization, Washington, D.C.
326. Zijlstra, E. E., M. Ali Siddig, A. M. El-Hassen, I. A. El-Toum, M. Satti, H. W. Ghalib, and P. A. Kager. 1991. Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan. Trans. R. Soc. Trop. Med. Hyg. 85:474-476.
327. Zijlstra, E. E., M. Ali Siddig, A. M. El-Hassen, I. A. El-Toum, M. Satti, H. W. Ghalib, and P. A. Kager. 1992. Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Trans. R. Soc. Trop. Med. Hyg. 86:505-507.
328. Zwingenberger, K., G. Harms, C. Pedrosa, S. Omena, B. Sandkramp, and S. Neifer. 1990. Determinants of the immune response in visceral leishmaniasis. Evidence for predominance of endogeneous IL4 over IFN-gamma production. Clin. Immunol. Immunopathol. 54:242-249.